Loading...

BrainsWay Ltd.

BRSYFPNK
Healthcare
Medical - Devices
$13.55
$0.00(0.00%)
U.S. Market opens in 4h 59m

BrainsWay Ltd. (BRSYF) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap542.4M
P/E Ratio74.94
EPS (TTM)$0.18
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$11.09
3 Months$6.53
1 Year Target$10.66

BRSYF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BRSYF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $10.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 74.94 and a market capitalization of 542.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
14.15%
3-Month Change
17.42%
6-Month Change
146.81%
Year-to-Date (YTD) Change
55.21%
1-Year Change
298.53%
3-Year Change
1356.99%
5-Year Change
234.57%
All-Time (Max) Change
392.73%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

120 Employees
IPO DateApr 21, 2011
CountryIL
Actively Trading

Frequently Asked Questions